Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when PROK files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsProKidney reports full-year 2025 financial results
Filed March 18, 2026 · Period ending March 18, 2026 · ~1 min read
Key Changes
-
high
ProKidney announced financial results for the year ended December 31, 2025 via press release. The 8-K references the results but does not include specific figures—investors must review the attached press release for revenue, earnings, and cash position details.
Item 2.02 verify on EDGAR →
Summary
ProKidney filed an 8-K to announce its full-year 2025 financial results through a press release dated March 18, 2026. The filing itself is procedural and does not contain the actual financial figures or performance metrics. Retail investors should review the attached press release (Exhibit 99.1) for specific details on revenue, profitability, cash burn, and any forward guidance the company provided.
This is a standard annual earnings disclosure for a clinical-stage biotech company. Watch for any updates on clinical trial progress or regulatory milestones that may have been discussed in the press release, as these typically drive valuation for pre-revenue biotechs like ProKidney.
Section-by-Section Diff
Event · Item 2.02 — Results of Operations and Financial Condition
Item 2.02 — Results of Operations and Financial Condition filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
On March 18, 2026, ProKidney Corp. (the "Company") issued a press release to announce its financial results for the year ended December 31, 2025.
The company disclosed its full-year 2025 financial results through a press release. The 8-K itself does not contain the actual financial figures or performance metrics, only references the press release as an attached exhibit. Investors should review the press release (Exhibit 99.1) for specific revenue, earnings, cash position, and other material financial data.
Event · Item 9.01 — Financial Statements and Exhibits
PROKIDNEY CORP. filed an 8-K attaching a press release dated March 18, 2026; no material business event disclosed in the filing body.
Added in current filing · verify on EDGAR →
99.1
Press Release dated March 18, 2026
The company attached a press release dated March 18, 2026 as Exhibit 99.1. The 8-K body does not describe the content of the press release, so the nature of the disclosure cannot be determined from this filing alone.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 4, 2026 · How we verify